Kumar P.Р., Bahrassa F., Espinosa M.G.
The role of radiotherapy in management of
metastatic bone disease // J. Nat. Med. Assoc. — 1978(12). — V. 70. — P. 900 911.
Kunkler I.H., Merrick M.V., Rodger A.
Bone scintigraphy in breast cancer: a nine
year follow up // Clin. Radiol. — 1985. — V. 36. — P. 279 282.
Kwa H.G., Cleton F., Wang D.J.
A prospective study of plasma prolactin levels and
subsequent risk of breast cancer // Int. J. of Cancer. — 1981. — V. 28(6). — P. 673 676.
Lactionov K. P., Pavlova Z.V., Isacova M.E.
Epidural opiate anakgesia in thoracal
cancer patients // Abstract I th European Federation of IASP Chapters «Pain in Europe». —
Verona Italy. — 1995. — P. 124.
Lagrange M., Ferrero J.M., Lagrange J.L., Machiavello J.C., Monticelli J., Bayle C.,
Creisson A., Namer M., Thyss A., Bourcier C., Gioanni J., Schneider M.
Non specifically
labelled cells that simulate bone marrow metastases in patients with non metastatic breast
cancer // J. Clin. Pathol.. — 1997. — V. 50(3). — P. 206 211.
Lafferty F.W.
Pseudohyperparathyroidism // Medicine. — 1966. — V. 45. —
P. 247 260.
Layer G., Rieker O., Dorr D., Schnakenberg D., Steudel A., Reiser M.
MR tomogra
phy and bone marrow scintigraphy in the screening of skeletal metastases in patients with
breast carcinoma // Rofo. Fortschr. Geb. Rontgenstr. Neuen. Bildgeb. Verfahr. — 1994. —
V. 160(5). — P. 448 452.
Layer G., Steudel A., Schuller H., van Kaick G., Grunwald F., Reiser M., Schild H.H.
Magnetic resonance imaging to detect bone marrow metastases in the initial staging of
small cell lung carcinoma and breast carcinoma // Cancer. — 1999. —V. 85(4). — P. 1004
1009.
Leddy E.T.
Roentgen treatment of metastasis to the vertebrae and bones of pelvis
from carcinoma of the breast // Am. J. Roentgenol. Radiat. Ther. — 1930. — V. 24. —
P. 657 672.
Lee C.K., Aeppli D.M., Unger J.
Strontium 89 chloride (Metastron) for palliative
treatment of bony metastases // Am. J. Clin. Oncol. — 1996. — V. 19(2). — P. 102 107.
Lees A.W., Giuffre C., Burns P.E.
и соавт. Oophorectomy versus radiation ablation
of ovarian function in patients with metastatic carcinoma of the breast // Surg. Gynecol.
Obstet. — 1980. — V. 151. — P. 721 724.
Leriche N., Bonneterre J.
Progestational agents and bone metastasis in breast cancer
// Bull. Cancer. — 1997. — V. 84(9). — P. 891 894.
Lerner H.J., Band P.R., Israel L.
Phase II study of tamoxifen; report of 74 patients
with stage IV breast cancer // Cancer Treat. Rep. — 1976. — V. 60. — P.1431 1435.
Lewington V.J.
Cancer therapy using bone seeking isotopes. // Phys. Med. Biol. —
1996. — V. 41(10). — P.2027 2042.
Lhotac S., Elavathil L.J., Duivenvoorden W.,
и соавт. Immunolocalization of matrix
metalloproteinases in human bone metastases of breast carcinoma (Abstract 461) //
American Society of Clinical Oncology 35th Annual Conference, Atlanta. — 1999.
Li F., Pitt P.I., Sherwood R., Barrett J., Houghton J., Parsons V., Moniz C.
Biochemical markers of bone turnover in women with surgically treated carcinoma of the
breast // Eur. J. Clin. Invest. — 1993. — V. 23(9). — P. 566 571.
Limouris G.S., Shukla S.K., Condi+Paphiti A., Gennatas C., Kouvaris I., Vitoratos N.,
Manetou A., Dardoufas C., Rigas V., Vlahos L.
Palliative therapy using rhenium 186
HEDP in painful breast osseous metastases // Anticancer Res. — 1997. — V. 17(3B). —
P. 1767 1772.
235
Костные метастазы рака молочной железы
